| Cameron ALEXANDER |
Polymer pro-drugs; RNA therapeutics; Nucleic acid vaccine formulations; Bio-responsive materials |
| Morgan ALEXANDER |
Biomaterials; Medical devices; Surface analysis |
| Claire ANDERSON |
Qualitative, mixed methods, health services research, education, workforce, pharmacy services |
| Naoko ARAKAWA |
Education and workforce development; Health system and policy; Public and global health; International pharmacy practice |
| Cynthia BOSQUILLON |
Drug delivery to the lungs |
| Matt BOYD |
Safety, Medicines Safety, Patient safety, pharmacy, community pharmacy, primary care, pharmacy education |
| Tracey BRADSHAW |
Cancer pharmacology; Cell biology; Drug discovery; Natural products |
| Jonathan BURLEY |
Raman spectroscopy; solids; formulation; pharmaceutical; XRPD; pre-formulation; high-throughput; high throughput |
| Weng CHAN |
Antibiotic discovery; Medicinal chemistry; Peptide chemistry; Macrocyclic peptides; Bioorganic chemistry; Antimicrobials; Bacterial virulence |
| Felicity DE COGAN |
Ocular drug delivery, skin drug delivery, microbiology, antimicrobial materials, novel therapeutics |
| Cornelia DE MOOR |
RNA biology, gene expression, RNA processing, translation, RNA stability, mRNA, polyadenylation, deadenylation, natural compounds, cordycepin, drug target identification, cancer, inflammation, pain, arthritis |
| James DIXON |
Gene delivery, gene editing, regenerative medicine, vaccines, mRNA, DNA, nanoformulation, trauma, orthopaedics, wound healing |
| Ingrid DREVENY |
Proteases in the ubiquitin system; Protein structure; X-ray crystallography, Structure-aided drug design; Protein engineering |
| Pavel GERSHKOVICH |
Pharmacokinetics, Pharmacodynamics, Biodistribution, Intestinal absorption, Lymphatic transport, Targeted drug disposition, Lymphatic targeting, Lymph nodes, Cancer, Immunotherapy, Immuno-oncology, Autoimmune diseases, HIV, AIDS, Antiretroviral therapy, Antiretroviral drugs, Lipophilic drugs, Cannabinoids, Cannabidiol, Prodrugs, Co-drugs, Lipid-based drug delivery, Lipidic formulations |
| Rian GRIFFITHS |
Mass spectrometry, Surface-sampling, Imaging (MSI), Biomolecules, Proteins, Lipids, Metabolites, Drug imaging, Biomedical Applications, Analytical workflows |
| David HEERY |
Gene regulation, transcription factors, nuclear receptors, epigenetic regulators, histone acetylation, CRISPR CAS9, protein interactions, cancer, leukemia, genetic syndromes, KAT6A/B, PIP5K1A, prostate cancer |
| Andrew HOOK |
Biomedical, analytical chemistry, pharmaceutical, materials science, computational chemistry |
| Naoto HORI |
Biophysics of nucleic acids, coarse-grained and atomistic molecular simulations, RNA structures and folding, nucleic acids condensates, RNA-protein complexes, enhanced sampling simulations |
| Catherine JOPLING |
RNA biology; microRNA biogenesis and function; Long noncoding RNA; RNA therapeutics; Molecular biology; Viruses; CRISPR/Cas9 |
| Laura KILPATRICK |
Molecular pharmacology; Receptor tyrosine kinases; G protein coupled receptors; Resonance energy transfer (RET); Fluorescent ligands; CRISPR/Cas9 |
| Dong-Hyun KIM |
Metabolomics, metabolite profiling, metabolic pathway profiling, targeted quantitative analysis, biological mass spectrometry, LC-MS, clinical/biological applications of LC-MS |
| Roger KNAGGS |
Pain management; Analgesic drugs; Evidence-based medicine and practice; Pharmacoepidemiology; Medicines safety |
| Charles LAUGHTON |
Structure-based drug design; Biomolecular simulation |
| Shailesh MISTRY |
G protein-coupled receptors (GPCRs); Medicinal Chemistry; Chemical Biology; Drug Discovery; Ligand design; Structure-Activity Relationships (SAR); Synthetic Organic Chemistry |
| Anna PICCININI |
inflammation, macrophage, macrophage fusion, signalling, microRNA, extracellular matrix, extracellular vesiscles, gene regulation, gene editing, siRNA, CRISPR |
| Frankie RAWSON |
Bioelectronics, Bioelectronic Medicine, Electroceuticals, Electrochemistry, Bioelectricity, Analytical Chemistry, Surface Analysis, Biosensors, Sensors, Cancer Electrical Signalling, Bio-nanotechnology, Quantum Therapeutics |
| Felicity ROSE |
Tissue engineering; biomaterials; regenerative medicine; bioprinting; stem cells |
| Snow STOLNIK-TRENKIC |
Drug delivery, nanomedicines, nanoparticles, liposomes, formulations for delivery of biological drugs |
| Li Shean TOH |
Medicines management; Medicines optimisation; Osteoporosis; Astropharmacy; Space medicine; Pharmacological Countermeasures; Health literacy; Intercultural competency; Interprofessional collaboration; Healthcare systems; Pharmacist; Pharmacists role; International; Qualitative research; Quantitative research; Policy; Patient experiences; Pharmacy practice |
| Lisa WHITE |
Biomaterials, materials characterisation, extracelluar matrix, hydrogels, microparticles, controlled release, encapsulation, cell therapies |
| Sebastiaan WINKLER |
Dysregulation of gene expression in cancer (RNA biology; lymphoma and leukaemia; protein structure; biochemistry); stability of messenger RNA (mRNA); non-canonical drug targets (enzyme inhibition; molecular pharmacology; assay development); infection by Helicobacter pylori (microbiology; adhesion; stomach cancer) |
| Jing YANG |
Biomaterials, 3D printing, bioprinting, Tissue Engineering, Regenerative Medicine, immunoengineering, immunotherapy |
| Mischa ZELZER |
Biointerfaces; Surface modification; Surface analysis; NCA polymerisation; Polymerisation kinetics and prediction; Supramolecular materials; Hydrogels; Enzyme responsive materials; Light responsive materials; Cell-material interactions; XPS; ToF-SIMS |
| Zheying ZHU |
Pre-clinical drug development; In vitro, ex vivo and in vivo models for drug evaluation; Gene therapy and delivery systems; Alzheimer's disease; GI infectious diseases; Cancers; Cardio regeneration |